$1.11
0.010.91%
마지막 업데이트: Oct 13, 9:34 AM
Benzinga
Benzinga
Benzinga
화요일, 10월 13
Benzinga
© 2026 Benzinga | All Rights Reserved
Telomir Pharmaceuticals (TELO) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.07 | $-0.07 | $-0.07 | $-0.07 |
| Actual | $-0.79 | $-0.03 | $-0.06 | $-0.03 |
| Surprise | -1028.6% | +57.1% | +14.3% | +57.1% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.04 | $-0.04 |
| Revenue | ||
| Consensus | — | — |
| 회계 분기 | 보고된 날짜 | 실제 EPS | 예상 EPS | 놀라다 % |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $-0.79 | $-0.07 | -1028.6 % |
| Q1 | May 14, 2026 | $-0.03 | $-0.07 | 57.1 % |
| Q4 | Mar 17, 2026 | $-0.06 | $-0.07 | 14.3 % |
| Q3 | Nov 10, 2025 | $-0.03 | $-0.07 | 57.1 % |